As of 2024-12-13, the Relative Valuation of Flexion Therapeutics Inc (FLXN) is (63.11) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.12 USD, the upside of Flexion Therapeutics Inc based on Relative Valuation is -792.0%.
The range of the Relative Valuation is (70.96) - (65.25) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 34.8x - 37.4x | 36.1x |
| Forward P/E multiples | 19.6x - 32.0x | 25.8x |
| Fair Price | (70.96) - (65.25) | (63.11) |
| Upside | -878.1% - -815.5% | -792.0% |
| Date | P/E |